U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07740317) titled 'Neurocognitive Trajectories After BCMA CAR-T' on July 28.
Brief Summary: The purpose of this research study is to evaluate cognitive changes over time in participants with relapsed or refractory multiple myeloma who have received chimeric antigen receptor T-cell therapy (CAR-T).
Study Start Date: Sept., 2026
Study Type: OBSERVATIONAL
Condition:
Multiple Myeloma (MM)
CART Therapy
Refractory Multiple Myeloma (RRMM)
Intervention:
OTHER: Standardized neurocognitive testing
Perform standardized neurocognitive testing at baseline and serially at 1-, 6-, and 12-months post-infusion.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: W...